CAS 865783-95-5

Formula: C19H22O7S

InChI: InChI=1S/C19H22O7S/c1-23-14-10-18(25-3)15(19(11-14)26-4)7-8-27(21,22)12-13-5-6-17(24-2)16(20)9-13/h5-11,20H,12H2,1-4H3/b8-7+

InChI key: GHPUSRLWNSTQIK-BQYQJAHWSA-N

SMILES: COC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)O

(E)-2-Methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)phenol

CAS: 865783-95-5

Formula: C₁₉H₂₂O₇S

Purity: 98.66%

Molecular weight: 394.4388

Ref: IN-DA01ENUB

ON-013100

CAS: 865783-95-5

ON-013100

Purity: ≥98%

Molecular weight: 394.44g/mol

Ref: 54-BUP09606

ON-013100

CAS: 865783-95-5

(E)-2-Methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)phenol

Formula: C₁₉H₂₂O₇S

Purity: 99%

Molecular weight: 394.44

Ref: IN-DG01108651

ON-013100

CAS: 865783-95-5

ON-013100 is an antineoplastic drug. ON-013100 also acts as a mitotic inhibitor that could inhibit Cyclin D1 expression.

Formula: C₁₉H₂₂O₇S

Purity: 98.27%

Color and Shape: Solid

Molecular weight: 394.44

Ref: TM-T16391

ON-013100

CAS: 865783-95-5

ON-013100 is a protease inhibitor that inhibits the activity of the chymotrypsin-like proteases and trypsin family. It has been shown to inhibit cancer cell growth and induce apoptosis. ON-013100 also has immunomodulatory effects, which have been demonstrated by an increase in tumor necrosis factor receptor 1 (TNFR1) expression, as well as an increase in the release of proinflammatory cytokines such as interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFα).

Formula: C₁₉H₂₂O₇S

Purity: Min. 95%

Molecular weight: 394.44 g/mol

Ref: 3D-QJB78395